PPARG and diabetes mellitus: Since its identification as the receptor for antidiabeticthiazolidinedione drugs, peroxisome proliferator-activatedreceptor-γ (PPARγ) has been the focus of pharmaceuticaldrug discovery programs directed toward finding betterdrugs for the treatment of diabetes, as well as the objectof basic research aimed at understanding its role inthe regulation of metabolism.